Arcellx, Inc. (ACLX)

114.99 +0.01 (+0.01%) USD  |  NASDAQ  |  Apr 22, 10:03
More

Arcellx Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade